We offer unparalleled expertise in developing generic pharmaceuticals and value added medicines and commercializing their innovation in the healthcare industry. We provide a broad portfolio of products and intellectual property to leading pharmaceutical companies.
Our people are our core competitive advantage that helps us being one of the fastest growing pharmaceutical development companies in Europe.
Commitment to quality
At PharOS we meet pharmaceutical industry’s demanding requirements while ensuring the success of the most challenging projects.
We work with an unwavering dedication to our people, clients, patients, safety & ethics.
LEADING AN EXCEPTIONAL TEAM
STELLA, THEODORE, PANAGIOTIS
For PharOS our customers, are our partners! Our aim is to extend the lifecycle of the product, as our people are able to provide an exceptional level of customer service and support, based on their expertise and professionalism. The boundaries of our business do not stop at European borders. We work with you globally across all geographic and cultural frontiers.
MANY YEARS OF UNPARALLELED EXPERIENCE
Establishment of the company
First project completed – 450 MAs granted simultaneously
Started own development projects
Among the first companies to run DCP via a fully compliant eCTD
Became founding member of the EuDRAcon®
PharOS Polska Establishment
First company to register
Exemestane in EU
Exemestane in EU
First pan-EU registration of immunosuppressant block-buster
First multinational approval of respiratory block-buster
First Greek company to become member of Medicines for Europe (former EGA)
1st submission in USA
1st submission in Japan
EU GMP for Batch Release accredited
Acquisition of the Hal Far ex-Arrow Pharma Plant in Malta (solid dosage forms manufacturing)
GMP Certification of the PharOS MT Hal Far Manufacturing site
Oncology Manufacturing Line in PharOS Malta
RnD Lab Metamorfossi Athens HQs